Genetic testing in 1,225 people with metastatic melanoma, the deadliest form of medlinkskin cancer/medlink, has identified a specific bmitochondrial

Genetic testing in 1,225 people with metastatic melanoma, the deadliest form of medlinkskin cancer/medlink, has identified a specific bmitochondrial

European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation in the European Union (EU) for Zemcelpro...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay...

As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds light on whether patients...

Breakthrough in targeting a colorectal cancer gene mutation with a promising drug combination.

Breakthrough in targeting a colorectal cancer gene mutation with a promising drug combination.

medlinkColorectal cancer/medlink may be treated more effectively by combining the bXPO1-targeting drug selinexor with the chemotherapy drug...

medlinkColorectal cancer/medlink may be treated more effectively by combining the bXPO1-targeting drug selinexor with the chemotherapy drug...